Stocklytics Platform
Asset logo for symbol SEEL
Seelos Therapeutics
SEEL64
$1.28arrow_drop_down47.55%-$1.16
High Growth
Penny Stock
Asset logo for symbol SEEL
SEEL64

$1.28

arrow_drop_down47.55%

Performance History

Chart placeholder
Key Stats
Open$1.46
Prev. Close$2.45
EPS351.04
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$397.98K
LOWHIGH
Day Range1.09
2.49
52 Week Range2.77
844.79
Ratios
Revenue-
EPS351.04

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc (SEEL) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of central nervous system (CNS) disorders. The company aims to address significant unmet needs in CNS conditions, including orphan indications. With a strong pipeline and a dedication to innovation, Seelos Therapeutics is poised for growth in the biopharmaceutical industry.
Seelos Therapeutics Inc's stock price history shows the company's performance in the market. Investors can analyze trends and patterns in the stock price to make informed decisions. The company's stock has shown fluctuations over time, reflecting the dynamic nature of the market. It is important for investors to stay informed about the latest updates and news regarding Seelos Therapeutics Inc to understand the factors influencing the stock's performance.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Raj Mehra J.D., Ph.D.
Headquarters
New York
Employees
16
Exchange
NASDAQ
add Seelos Therapeutics  to watchlist

Keep an eye on Seelos Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Seelos Therapeutics 's (SEEL) price per share?

The current price per share for Seelos Therapeutics (SEEL) is $1.28. The stock has seen a price change of -$1.17 recently, indicating a -47.55% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Seelos Therapeutics (SEEL)?

For Seelos Therapeutics (SEEL), the 52-week high is $844.8, which is 65.9K% from the current price. The 52-week low is $2.77, the current price is -53.79% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Seelos Therapeutics (SEEL) a growth stock?

Seelos Therapeutics (SEEL) has shown an average price growth of -6.8% over the past three years. It has received a score of 97 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Seelos Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Seelos Therapeutics (SEEL) stock price performance year to date (YTD)?

As of the latest data, Seelos Therapeutics (SEEL) has a year-to-date price change of -99.28%. Over the past month, the stock has experienced a price change of 26.73%. Over the last three months, the change has been -78.56%. Over the past six months, the figure is -95.79%. Looking at a longer horizon, the five-year price change stands at -99.96%.
help

Is Seelos Therapeutics (SEEL) a profitable company?

Seelos Therapeutics (SEEL) has a net income of -$37.88M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -834.84% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $2.15M. Operating income is noted at -$40.5M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of Seelos Therapeutics (SEEL)?

Seelos Therapeutics (SEEL) has a market capitalization of $397.98K. The average daily trading volume is 1.34, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level